Sectoral Asset Management as of Sept. 30, 2015
Portfolio Holdings for Sectoral Asset Management
Sectoral Asset Management holds 77 positions in its portfolio as reported in the September 2015 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Biogen Idec (BIIB) | 8.4 | $182M | 625k | 291.81 | |
Gilead Sciences (GILD) | 8.3 | $182M | 1.9M | 98.19 | |
Celgene Corporation | 6.3 | $137M | 1.3M | 108.17 | |
Regeneron Pharmaceuticals (REGN) | 5.2 | $114M | 244k | 465.14 | |
Alexion Pharmaceuticals | 5.2 | $113M | 722k | 156.39 | |
BioMarin Pharmaceutical (BMRN) | 4.7 | $102M | 970k | 105.32 | |
Incyte Corporation (INCY) | 4.5 | $98M | 887k | 110.33 | |
Amicus Therapeutics (FOLD) | 3.9 | $86M | 6.1M | 13.99 | |
Amgen (AMGN) | 3.5 | $77M | 555k | 138.32 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $77M | 734k | 104.14 | |
Thermo Fisher Scientific (TMO) | 3.4 | $74M | 606k | 122.28 | |
Merck & Co (MRK) | 2.5 | $54M | 1.1M | 49.39 | |
Pfizer (PFE) | 2.5 | $54M | 1.7M | 31.41 | |
Seattle Genetics | 2.2 | $49M | 1.3M | 38.56 | |
Portola Pharmaceuticals | 2.1 | $46M | 1.1M | 42.62 | |
Allergan | 1.8 | $39M | 142k | 271.81 | |
Intercept Pharmaceuticals In | 1.7 | $36M | 220k | 165.86 | |
Halozyme Therapeutics (HALO) | 1.6 | $36M | 2.7M | 13.43 | |
Medtronic (MDT) | 1.6 | $35M | 526k | 66.94 | |
Teva Pharmaceutical Industries (TEVA) | 1.5 | $34M | 595k | 56.46 | |
Align Technology (ALGN) | 1.3 | $29M | 512k | 56.76 | |
Dex (DXCM) | 1.3 | $28M | 323k | 85.86 | |
Shire | 1.1 | $25M | 122k | 205.23 | |
Alder Biopharmaceuticals | 1.1 | $25M | 763k | 32.76 | |
United Therapeutics Corporation (UTHR) | 1.1 | $23M | 176k | 131.24 | |
St. Jude Medical | 1.0 | $22M | 355k | 63.09 | |
UnitedHealth (UNH) | 1.0 | $22M | 191k | 116.01 | |
Edwards Lifesciences (EW) | 1.0 | $22M | 153k | 142.17 | |
Aimmune Therapeutics | 0.9 | $20M | 793k | 25.32 | |
Ptc Therapeutics I (PTCT) | 0.8 | $18M | 690k | 26.70 | |
Chimerix (CMRX) | 0.8 | $18M | 477k | 38.20 | |
Pronai Therapeutics | 0.8 | $17M | 863k | 20.04 | |
Mylan Nv | 0.8 | $17M | 417k | 40.26 | |
Dr. Reddy's Laboratories (RDY) | 0.8 | $16M | 255k | 63.91 | |
Relypsa | 0.7 | $16M | 842k | 18.51 | |
Uniqure Nv (QURE) | 0.7 | $16M | 762k | 20.45 | |
Acceleron Pharma | 0.7 | $15M | 612k | 24.90 | |
Tg Therapeutics (TGTX) | 0.7 | $15M | 1.5M | 10.08 | |
Cara Therapeutics (CARA) | 0.7 | $15M | 1.0M | 14.29 | |
Novartis (NVS) | 0.6 | $13M | 145k | 91.92 | |
Advaxis | 0.6 | $13M | 1.3M | 10.23 | |
Novo Nordisk A/S (NVO) | 0.6 | $13M | 235k | 54.24 | |
HeartWare International | 0.5 | $12M | 225k | 52.31 | |
Intuitive Surgical (ISRG) | 0.5 | $11M | 24k | 459.58 | |
NxStage Medical | 0.5 | $11M | 712k | 15.77 | |
Regenxbio Inc equity us cm (RGNX) | 0.5 | $11M | 507k | 21.35 | |
Immune Design | 0.5 | $10M | 846k | 12.20 | |
Teladoc (TDOC) | 0.4 | $9.3M | 418k | 22.29 | |
Sagent Pharmaceuticals | 0.4 | $9.0M | 586k | 15.33 | |
Acadia Healthcare (ACHC) | 0.4 | $8.5M | 128k | 66.27 | |
CIGNA Corporation | 0.3 | $7.5M | 56k | 135.02 | |
Karyopharm Therapeutics (KPTI) | 0.3 | $7.5M | 713k | 10.53 | |
Tetraphase Pharmaceuticals | 0.2 | $5.2M | 692k | 7.46 | |
Perrigo Company (PRGO) | 0.2 | $4.2M | 27k | 157.25 | |
Valeant Pharmaceuticals Int | 0.1 | $3.2M | 18k | 178.37 | |
Zs Pharma | 0.1 | $2.8M | 42k | 65.67 | |
Momenta Pharmaceuticals | 0.1 | $2.5M | 150k | 16.41 | |
Mallinckrodt Pub | 0.1 | $2.4M | 38k | 63.94 | |
Eagle Pharmaceuticals (EGRX) | 0.1 | $2.1M | 28k | 74.03 | |
Akorn | 0.1 | $2.0M | 69k | 28.51 | |
McKesson Corporation (MCK) | 0.1 | $1.7M | 9.2k | 185.06 | |
Impax Laboratories | 0.1 | $1.8M | 52k | 35.21 | |
Alkermes (ALKS) | 0.1 | $1.8M | 30k | 58.68 | |
Jazz Pharmaceuticals (JAZZ) | 0.1 | $1.6M | 12k | 132.84 | |
Oncomed Pharmaceuticals | 0.1 | $1.8M | 109k | 16.59 | |
Endo International (ENDPQ) | 0.1 | $1.7M | 25k | 69.29 | |
Lannett Company | 0.1 | $1.4M | 34k | 41.52 | |
DepoMed | 0.1 | $1.4M | 72k | 18.85 | |
Horizon Pharma | 0.1 | $1.3M | 68k | 19.82 | |
Nektar Therapeutics (NKTR) | 0.1 | $1.1M | 104k | 10.96 | |
China Biologic Products | 0.0 | $614k | 6.8k | 89.77 | |
Cambrex Corporation | 0.0 | $610k | 15k | 39.69 | |
Pacira Pharmaceuticals (PCRX) | 0.0 | $754k | 18k | 41.07 | |
Ascendis Pharma A S (ASND) | 0.0 | $550k | 31k | 17.68 | |
Catalent (CTLT) | 0.0 | $473k | 19k | 24.32 | |
Amphastar Pharmaceuticals (AMPH) | 0.0 | $489k | 42k | 11.70 | |
Coherus Biosciences (CHRS) | 0.0 | $331k | 17k | 20.06 |